|
|
U.S. investors and individual shareholders
The Sanofi Investor Relations team is committed to providing the investment community with timely, transparent information on the Group’s business, organization and performance. A dedicated team is available in the U.S. to answer the questions of U.S. investors and individual shareholders.
For general inquiries, please call the switchboard at the U.S. headquarters: +1 908 981 5000
U.S. Investor Relations
If you are a U.S. individual shareholder please contact:
Institutional investors should contact:
Address at the U.S. headquarters:
- Sanofi
Investor Relations
55 Corporate Drive
Bridgewater, NJ 08807
JPMorgan Chase Bank, N.A.
JPMorgan Chase Bank, N.A. sponsors and administers our American Depositary Receipts (ADR) program. You can contact their Sanofi shareholder services at: - Toll-free number in the U.S.: (1) 877 272 9475
- For international callers: (1) 651 453 2128
- Email: jpmorgan.adr@wellsfargo.com
Addresses
- Regular correspondence:
JPMorgan Chase Bank, NA
P.O. BOX 64504
St. Paul, MN 55164-0504
- Delivery of stock certificates and overnight mail:
JPMorgan Chase Bank, NA
161 N Concord Exchange
South St. Paul, MN 55075
- General inquiries concerning ADRs:
J.P. Morgan
American Depositary Receipts
1 Chase Manhattan Plaza, Floor 58
New York, NY 10005
E-mail: adr@jpmorgan.com
|
Sanofi at a glance
Factsheets
Direct access
ADR program
Further information
Event
Publications
SEC Filings
|